Clinical Trial Update: Intraosseous Administration of Mesenchymal Stromal Cells for Patients With Graft Failure After Allo-HSCT [Phase 3]

View source ↗

Summary

Phase 3 trial update on intraosseous administration of mesenchymal stromal cells for graft failure after allogeneic hematopoietic stem cell transplantation (all…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft Failure After Allogeneic Hematopoietic Stem Cell Transplantation

Drugs mentioned

• Mesenchymal stromal cells

Snippet

Sponsor: National Research Center for Hematology, Russia | Conditions: Mesenchymal Stem Cell Transplantation | Phase 3 | Status: UNKNOWN